Immunity and tolerance induced by two antigens in individual B cells

Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis.

Kidney international·2007

Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes.

European journal of immunology·2001

PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13.

Developmental biology·2000

The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.

Journal of immunology (Baltimore, Md. : 1950)·2000

Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.

European cytokine network·1999

Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis.

Annals of neurology·1999

Lymphocytes migration into membrane filters: divergent effects of syngeneic mouse serum and lymph.

Annales d'immunologie·1984

Effect of mycobacterial lipids on membrane fluidity and natural killer cell-mediated cytotoxicity.

Annales d'immunologie·1984

Heterogeneity of human B lymphocytes as revealed by monoclonal antibodies.

Annales d'immunologie·1984

Effects of T mitogens on in vivo antibody production to a T-dependent antigen in lines of mice genetically selected for high or low in vitro responsiveness to PHA.

Annales d'immunologie·1984

Cyclosporin A inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion.

Annales d'immunologie·1984

Speculations on how Ia antigens (Ir genes) influence the specificity of the immune response.

Annales d'immunologie·1984

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Expert opinion on pharmacotherapy·2026

Related Experiment Videos

Immunity and tolerance induced by two antigens in individual B cells

Related Concept Videos

Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis.

Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes.

PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13.

The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.

Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.

Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis.

Lymphocytes migration into membrane filters: divergent effects of syngeneic mouse serum and lymph.

Effect of mycobacterial lipids on membrane fluidity and natural killer cell-mediated cytotoxicity.

Heterogeneity of human B lymphocytes as revealed by monoclonal antibodies.

Effects of T mitogens on in vivo antibody production to a T-dependent antigen in lines of mice genetically selected for high or low in vitro responsiveness to PHA.

Cyclosporin A inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion.

Speculations on how Ia antigens (Ir genes) influence the specificity of the immune response.

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Related Experiment Videos

Immunity and tolerance induced by two antigens in individual B cells

Related Concept Videos

Related Articles